NASDAQ: MDCX
Medicus Pharma Revenue

Medicus Pharma revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MDCX annual revenue was $0.0, with N/A growth year-over-year.

MDCX revenue history

Current Revenue
$0.0
Current Earnings
-$11.2M
Current Profit Margin
0%

Be the first to know when MDCX announces revenue.

MDCX Revenue History By Year

MDCX Yearly RevenueMDCX RevenueMDCX ChangeMDCX Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Medicus Pharma Revenue FAQ

What was MDCX's revenue last quarter?

Medicus Pharma (NASDAQ: MDCX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Medicus Pharma's revenue was $0.00.

What was Medicus Pharma's revenue in 2024?

Medicus Pharma's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Medicus Pharma make in a day?

Based on Medicus Pharma annual revenue for the past two years, MDCX makes an average of $0.00 per day.

What was Medicus Pharma's annual revenue growth in the past year?

As of Q2 2025, Medicus Pharma's revenue has grown null year over year. Medicus Pharma's revenue in the past year totaled $0.00.

How much does Medicus Pharma make in a year?

Medicus Pharma's revenue by year for the past two years is:
  • Medicus Pharma's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Medicus Pharma's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.